https://www.pharmaceutical-technology.com/data-insights/pieris-pharmaceuticals-gets-grant-for-patent-granted-for-novel-muteins-derived-from-human-lipocalin/
Discover the groundbreaking patent by Pieris Pharmaceuticals Inc for novel muteins derived from human lipocalin 2, targeting Alzheimer's disease and tumor...
meta titlepieris pharmaceuticalsincpatentnovel
https://www.pharmaceutical-technology.com/data-insights/pieris-pharmaceuticals-gets-grant-for-fusion-polypeptide-binding-cd137-and-gpc3-for-cancer-treatment/
Discover the groundbreaking fusion polypeptide patent by Pieris Pharmaceuticals targeting CD137 and GPC3 for cancer treatment and immune modulation. Explore...
pieris pharmaceuticalsincpatentfusionpolypeptide
https://www.ig.com/nl/aandelen/markten-aandelen/pieris-pharmaceuticals-inc
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat patients... [NL]
pieris pharmaceuticalskoersincaandeel